Head to head
Intuitive Surgical vs Becton Dickinson & Co
Side-by-side on the measures that matter, with a plain-English read. Full detail: ISRG · BDX
ISRG
Intuitive Surgical
414.52+2.41%
1-year price shape — -6% over the period
Quant Rating D · 30/100
vs
BDX
Becton Dickinson & Co
180.16-0.08%
1-year price shape — +22% over the period
Quant Rating C · 64/100
1-year performance, rebased to 100
Intuitive Surgical edges it on the scoreable measures. Intuitive Surgical trades cheapest on trailing earnings; Intuitive Surgical earns the most per share.
| ISRG | BDX | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Instruments & Supplies | Medical Instruments & Supplies |
| Last price | 414.52 | 180.16 |
| Change today | +2.41% | -0.08% |
| 1-year return | -6.0% | +22.0% |
| Market cap | $146.44B | $49.07B |
| 52-week range | 328.57 – 603.88 | 124.51 – 191.94 |
| Valuation | ||
| P/E (TTM) | 47.54 | 54.43 |
| P/E percentile, own 5-yr range | 6th | 92nd |
| P/B | 8.06 | 2.01 |
| Dividend yield | 0.00% | 2.33% |
| Profitability & growth | ||
| EPS (TTM) | 7.87 | 5.82 |
| Net profit (TTM) | $2.78B | $1.59B |
| Revenue (TTM) | $11.03B | $23.25B |
| Revenue growth (YoY) | +18.5% | +5.4% |
| Gross margin | 66.7% | 46.9% |
| Operating margin | 31.3% | 14.5% |
| Net margin | 28.4% | 4.2% |
| Free cash flow (TTM) | $3.22B | $2.51B |
| Ownership & sentiment | ||
| Institutional ownership | 88.8% | 98.4% |
| Insider activity (12mo) | 21 buy / 29 sell | 24 buy / 21 sell |
| Short interest (% of float) | 2.3% | 4.2% |
| Analyst consensus | 86% buy / 14% hold (21) | 56% buy / 44% hold (9) |
| Analyst price target | $490 (+18%) | $195 (+8%) |
| StockVane view | ||
| StockVane Quant Rating | D (30) | C (64) |
| Company | ||
| Employees | 17,021 | 72,000 |
| Founded | 1995 | 1897 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.